Cardinal Health: Why This Essential Healthcare Distributor Deserves A Buy Rating

Cardinal Health receives a Buy rating, supported by defensive business fundamentals, strong adjusted EPS growth, and strategic expansion into specialty healthcare. CAH's Q3FY26 showed 11% revenue growth and 35% adjusted EPS growth, though GAAP results were pressured by higher costs and special items. Valuation is at a premium with a Forward P/E of 21.64x, justified by improving profitability and cash flow, but future upside depends on sustained margin gains. Key risks include persistent margin pressure and legal liabilities, particularly opioid litigation, requiring close monitoring of operational efficiency and cash flow.

Cardinal Health, Inc. (CAH) is one of the largest U.S. healthcare companies, headquartered in Dublin, Ohio. The company plays a key role in the distribution of pharmaceutical and medical products, connecting manufacturers with hospitals, pharmacies, and other healthcare providers.